Sponsored by:

Molecular Imaging: Page 116

Blue Earth starts second phase III trial for PET agent
By AuntMinnie.com staff writers
Bracco molecular imaging subsidiary Blue Earth Diagnostics has begun a second phase III clinical trial of its investigational radiohybrid PET imaging agent for prostate cancer.
July 22, 2020
2019 04 17 20 48 2514 Prostate 3 D 400
Clarity begins trial for pediatric neuroblastoma therapy
By AuntMinnie.com staff writers
Radiopharmaceutical firm Clarity Pharmaceuticals has begun recruitment for a phase I/IIA clinical trial evaluating its SARTATE peptide receptor radionuclide therapy for pediatric patients with neuroblastoma.
July 22, 2020
2020 07 23 21 58 4280 Cancer Radiotherapy 400
AC Immune's PET tracer to be presented at AAIC
By AuntMinnie.com staff writers
A researcher from Swiss biopharmaceutical company AC Immune will present findings on the company's alpha-synuclein-PET tracer program at the virtual 2020 Alzheimer's Association International Conference (AAIC).
July 22, 2020
2020 01 30 19 25 3996 Brain Dementia Leaves 400
Clarity, ImaginAb team to develop theranostic agents
By AuntMinnie.com staff writers
Radiopharmaceutical firm Clarity Pharmaceuticals and imaging agent developer ImaginAb are collaborating to develop new targeted theranostic products for a range of cancer types.
July 20, 2020
2019 01 31 19 13 5426 Radiotherapy 400
Molecular imaging mourns death of Stanford's Gambhir
By Brian Casey
The molecular imaging and radiology communities are mourning the death of Dr. Sanjiv Sam Gambhir, PhD, the chair of radiology at Stanford University, who died of cancer on July 18. He was 57.
July 19, 2020
2020 07 20 22 02 5764 2020 07 20 Gambhir Sam 20200720223222
SNMMI 2020: AI analysis of PET could help classify prostate cancer
By Erik L. Ridley
An artificial intelligence (AI) algorithm may be able to assist in classifying prostate lesions on 3D prostate-specific membrane antigen-PET exams, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
July 16, 2020
2019 04 17 20 48 2514 Prostate 3 D 400
SNMMI 2020: Researchers develop novel prostate cancer agents
By Theresa Pablos
Research on prostate cancer imaging agents that can be produced faster and cheaper than current radiotracers -- and also have therapeutic potential -- was presented by a group from Memorial Sloan Kettering Cancer Center at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.
July 16, 2020
2020 07 15 23 29 3710 Cancer Cells Prostate 400
SNMMI 2020: PET radiotracer measures stroke recovery
By Theresa Pablos
A new PET radiotracer may one day help clinicians evaluate stroke recovery, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting. Researchers used the radiotracer, F-18 SynVesT-2, to assess synaptic density in rat brains.
July 14, 2020
2020 07 15 01 23 2059 2020 07 15 Pet Radiotracer Stroke 20200715010605
Bayer adds connectivity to Intego PET injector
By AuntMinnie.com staff writers
Bayer has added features to its Medrad Intego PET radiopharmaceutical infusion system that improve the injector's connectivity with HIS and PACS, and also add radiation dose tracking features.
July 14, 2020
2019 12 19 17 46 9582 Bayer Rsna 2019 400
SNMMI 2020: PET tracer could image, treat glioblastoma
By Erik L. Ridley
A new, relatively long-lived PET tracer can safely and effectively image patients with glioblastoma, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The tracer also shows potential as a radiotheragnostic agent.
July 14, 2020
2020 07 15 00 25 0966 2020 07 14 Snmmi Radiotracer Glioblastoma 20200715001717
SNMMI 2020: PSMA-PET/CT changes prostate cancer management
By Kate Madden Yee
PET/CT imaging with an F-18 DCFPyL prostate-specific membrane antigen (PSMA) radiopharmaceutical changed prostate cancer management in two-thirds of cases, according to research presented July 13 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.
July 14, 2020
2020 07 14 23 23 6106 2020 07 13 Snmmi Pet Ct Prostate Thumb
SNMMI 2020: PET/MRI combo tracks osteoarthritis progression
By AuntMinnie.com staff writers
A new functional bone imaging technique that combines PET and MRI shows that bone metabolism is higher in patients with osteoarthritis in the knee, according to research presented July 13 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.
July 14, 2020
2020 07 14 20 06 2345 2020 07 13 Snmmi Bone Imaging 20200714204612
Previous Page
Page 116 of 614
Next Page